Back to top
more

Patterson Companies (PDCO)

(Real Time Quote from BATS)

$21.10 USD

21.10
758,900

-0.83 (-3.79%)

Updated Sep 5, 2024 03:55 PM ET

After-Market: $21.10 0.00 (0.00%) 4:18 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value F Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 32% (170 out of 251)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Analysts Estimate Patterson Cos. (PDCO) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Patterson Cos. (PDCO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Here's Why You Should Retain Patterson Companies (PDCO) Stock

by Zacks Equity Research

Patterson Companies (PDCO) continues to benefit from strength in the Animal Health business and dental business.

Here's Why You Should Hold on to Illumina (ILMN) for Now

by Zacks Equity Research

Investors are optimistic about Illumina (ILMN) owing to its strength in international markets and notable strategic partnerships.

Alcon (ALC) Launches Preservative-Free Drops for Dry Eye Relief

by Zacks Equity Research

Alcon's (ALC) new preservative-free solution for patients with dry eye symptoms is the latest addition to its leading global artificial tear brand Systane.

Integra (IART) Announces Preliminary Q4 & '21 Sales Results

by Zacks Equity Research

Integra's (IART) preliminary revenue results and recent plans to implement a $125-million share repurchase instill investor optimism.

Cardiovascular Systems (CSII) Coronary Sales Up Amid COVID Woe

by Zacks Equity Research

Cardiovascular Systems (CSII) continues to experience strong demand for physician training and certification in all international markets.

Hologic (HOLX) Up on Preliminary Q1 Organic Sales Growth

by Zacks Equity Research

Hologic's (HOLX) Diagnostics division's preliminary numbers show a strong rebound in the base business.

Here's Why You Should Hold on to Align Technology (ALGN) Now

by Zacks Equity Research

Investors are optimistic about Align Technology (ALGN) given huge market potential in its Invisalign brand and strategic partnerships.

Medtronic (MDT) Gets MHLW Approval for Micra AV Sale in Japan

by Zacks Equity Research

The Micra AV approval is likely to boost Medtronic's (MDT) Cardiac Rhythm Management business while delivering the benefits of leadless pacing in Japan.

Illumina (ILMN) Announces Preliminary Q4 Sales, Issues '22 View

by Zacks Equity Research

Illumina's (ILMN) preliminary fourth-quarter results, latest partnership deals and a robust pipeline of technologies instill investor optimism.

IDEXX's (IDXX) Low LPD Sales, Rise in Expenses Dampen Growth

by Zacks Equity Research

Distributor purchasing dynamics have an impact on IDEXX's (IDXX) reported sales of CAG products.

Medtronic (MDT) to Buy Affera, Expand in Electrophysiology

by Zacks Equity Research

Affera's full suite of solutions and technologies will complement Medtronic's (MDT) existing atrial and ventricular arrhythmia disease management portfolio.

PDCO vs. CNMD: Which Stock Is the Better Value Option?

by Zacks Equity Research

PDCO vs. CNMD: Which Stock Is the Better Value Option?

Here's Why You Should Retain Patterson Companies (PDCO) Stock

by Zacks Equity Research

Patterson Companies (PDCO) continues to benefit from strength in Animal Health business and dental business.

PDCO or CNMD: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

PDCO vs. CNMD: Which Stock Is the Better Value Option?

Patterson Companies (PDCO): The Perfect Mix of Value and Rising Earnings Estimates?

by Zacks Equity Research

Patterson Companies (PDCO) seems to be a good value pick, as it has decent revenue metrics to back up its earnings, and is seeing solid earnings estimate revisions as well.

After Plunging 15.7% in 4 Weeks, Here's Why the Trend Might Reverse for Patterson Cos. (PDCO)

by Zacks Equity Research

Patterson Cos. (PDCO) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

Patterson Cos. (PDCO) Moves to Buy: Rationale Behind the Upgrade

by Zacks Equity Research

Patterson Cos. (PDCO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

PDCO vs. CNMD: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research

PDCO vs. CNMD: Which Stock Is the Better Value Option?

Patterson Companies (PDCO) Beats on Q2 Earnings & Revenues

by Zacks Equity Research

Patterson Companies' (PDCO) fiscal second-quarter 2022 results benefit from strength in the Animal Health segment.

Patterson Cos. (PDCO) Q2 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

Patterson Cos. (PDCO) delivered earnings and revenue surprises of 16% and 4.24%, respectively, for the quarter ended October 2021. Do the numbers hold clues to what lies ahead for the stock?

What's in Store for Patterson Companies' (PDCO) Q2 Earnings?

by Zacks Equity Research

Patterson Companies' (PDCO) fiscal second-quarter results are likely to reflect improvement at Dental segment.

Analysts Estimate Patterson Cos. (PDCO) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Patterson Cos. (PDCO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Here's Why You Should Retain Patterson Companies (PDCO) Stock

by Zacks Equity Research

Patterson Companies (PDCO) continues to benefit from strength in Animal Health business and dental business.

PDCO vs. WST: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research

PDCO vs. WST: Which Stock Is the Better Value Option?